TW
BSX icon

Traveka Wealth’s Boston Scientific BSX Stock Holding History

Traveka Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,188
Closed -$200K – 205
2026
Q1 		$200K Sell
3,188
-351
-10% -$28.1K 0.08% 179
2025
Q4 		$337K Buy
3,539
+37
+1% +$3.63K 0.14% 121
2025
Q3 		$342K Buy
3,502
+27
+0.8% +$2.8K 0.15% 106
2025
Q2 		$373K Sell
3,475
-2
-0.1% -$202 0.2% 85
2025
Q1 		$351K Buy
3,477
+33
+1% +$3.32K 0.2% 87
2024
Q4 		$308K Buy
3,444
+206
+6% +$18.1K 0.17% 92
2024
Q3 		$271K Buy
3,238
+72
+2% +$5.68K 0.14% 99
2024
Q2 		$244K Buy
3,166
+187
+6% +$13.7K 0.12% 102
2024
Q1 		$204K Buy
+2,979
New +$192K 0.09% 125

Other funds holding BSX

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Traveka Wealth's BSX Position: Q2 2026 in Review

Traveka Wealth sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,188 shares — an estimated $200K sold.

Traveka Wealth first reported a position in BSX in Q1 2024 and held it in 9 quarters. The position peaked at $373K in Q2 2025. 570 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Traveka Wealth reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Traveka Wealth sold 3,188 Boston Scientific shares in Q2 2026, an estimated $200K.
  • Traveka Wealth first reported a position in Boston Scientific in Q1 2024 and held it in 9 quarters.
  • Traveka Wealth's Boston Scientific position peaked at $373K in Q2 2025.
  • 570 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.